Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...

Q3 2024 sales revenue increased 164% year-over-year to $135 thousand.Sequential (quarter-over-quarter) net product revenue growth of 8.3%.Gross ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting the drug.

This regular publication from DLA Piper focuses on helping banking and financial services clients navigate the ever-changing regulatory landscape. In ...